S.S. v. HHS - DTaP, left thigh lipoatrophy / lipodystrophy (2025)
Case summary [AI summaries can sometimes make mistakes]
On October 26, 2021, S.S.'s petitioner filed a claim alleging that six-month childhood vaccines administered on November 25, 2019 caused left-thigh lipoatrophy. S.S. was born on May 24, 2019 and was six months old at vaccination.
The vaccines were Pentacel, covering DTaP, Hib, and IPV components, plus pneumococcal conjugate vaccine and hepatitis B vaccine. The causation dispute turned on the injection site and whether the left thigh indentation followed the vaccines or earlier antibiotic/steroid injections.
S.S. had received Kenalog in the right hip and clindamycin in the left hip on October 30, 2019. After the November vaccinations, the record described a left thigh indentation and bruised appearance, with first documented medical attention on December 26, 2019 and later concerns about range of motion, instability, and atrophy.
Treaters considered fatty necrosis and cosmetic lipoatrophy. Petitioner relied on dermatologist Dr.
Kyle Amber, who attributed the left thigh lipoatrophy to vaccination. Respondent relied on dermatologist Dr.
Ginette Okoye, who attributed the problem to the earlier clindamycin injection. Special Master Thomas L.
Gowen found entitlement after resolving the site and causation issues. A corrected stipulation later awarded an annuity for future benefit and $956.51 to satisfy an Oklahoma Health Care Authority Medicaid lien.
Source PDFs
USCOURTS-cofc-1_21-vv-02073